Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
116.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
98.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
100.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
94.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
113.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
105.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
101.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
110.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
119.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
105.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |